ALEMBIC PHARMACEUTICALS : USFDA INSPECTION COMPLETED AT BIOEQUIVALENCE FACILITY

• Successful completion of unannounced USFDA onsite inspection at the Company's Bioequivalence Facility in Vadodara, Gujarat. • No Form 483 observations were noted during the inspection. • The inspection was conducted from August 31, 2026, to September 10, 2026.

Alembic Pharmaceuticals Ltd

Open attachment

← Back to feed